| abstract |
A pharmaceutical composition comprises a therapeutically effective isomer of a betamimetic agent or a salt, solvate, ester, prodrug, polymorph or derivative thereof substantially free of the less therapeutically effective isomer(s) of said agent, and a mucolytic agent or salt, solvate, ester, prodrug, polymorph, enantiomer or derivative thereof. A preferred composition comprises R-salbutamol and ambroxol. Methods of making the compositions of the invention are provided, as is their use in therapy. |